Biomarkers Flashcards

1
Q

Define biomarker.

A

characteristic that is objectively measured & evaluated as an indicator of normal biological/pathogenic processes or response to a therapeutic invention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Where can you measure biomarkers?

A

Serum
urine
tissue
saliva
blood cells
any accessible body fluid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are technologies used to measure biomarkers?

A

Ion selective electrodes
Immunoassay
Immunohistochemistry
spectrophotometry
PCR/RT-PCR
DNA sequencing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Where does biomarker testing occur?

A

Hospital laboratories
commercial laboratories
point-of-care
over the counter
pharmaceutical industry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

When are biomarkers used?

A

Disease detection & management
Drug discovery and evaluation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are 6 uses for biomarkers?

A

Risk identification
screening
aiding diagnosis
assessing prognosis
therapy prediction
monitoring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are 4 predisposing genes for disease?

A

BRCA1 - breast, prostrate & ovarian
BRCA2 - breast, prostrate & ovarian
HFE - haemochromatosis
CF gene - cystic fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are 3 screening tests?

A

mammography
FOB (Crc)
PAP/HPV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is PSA screening test used for?

A

For prostrate cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are benefits of PSA?

A

Vast majority of cancers detected are organ defined
detect PCA 10 yrs before clinical evidence of disease
detected at lower stage & more differentiated
death rates for PCA have decreased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are 2 arguments against PSA?

A

Overdiagnosis
overtreatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are 5 diagnostic biomarkers?

A

Glucose - diabetes
Troponin - MI
urea & creatinine - renal disease
Albumin - liver
t4/TSH - thyroid disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are prognostic markers used to assess?

A

Disease aggressiveness & patient outcome -> avoids under/over treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the challenge with lymph-node negative BC?

A

Differentiate the majority who are cured from surgery from the minority that need chemo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What test was used to identify if chemo wasnt needed?

A

uPA & PAI-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Why do we need therapy predictive markers?

A

Only a proportion of Pts with a specific disease respond to a specific therapy
many therapies are toxic
some therapies are v expensive

17
Q

What are 6 predictive biomarkers used to target in cancers?

A

HER2 - breast
EGFR - lung
KRAS/NRAS - CRC
BRAF - melanoma
ALK - lung
ER/PR - breast

18
Q

What is a benefit of Herceptin in HER2+ BC?

A

10-15% of Pts with metastatic BC now have long-term outcome & may be cured

19
Q

How amplified in the HER2 gene in BC?

20
Q

What does increased expression of HER2 dfrive?

A

BC formation & metastasis

21
Q

What do Mabs against HER2 block?

A

HER2 signalling -> blocking HER2-driven proliferation

22
Q

How is monitoring used for serial levels of markers?

A

Serial levels of markers can detect recurrent or metastatic disease prior to clinical or radiological criteria
Determines if Pt is responding to treatment

23
Q

What are future developments for tumour markers?

A

Mutated genes (ctDNA)
Methylated genes
circulating tumour cells
gene expression microarray
proteomics
miRNAs

24
Q

What are 5 major causes of attrition in drug development?

A

Lack of efficacy
toxicity
commercial factors
costs
bioavailability

25
Q

How is drug development being improved

A

Biomarkers predicting drug efficacy
biomarkers that predict toxicity